Ferozsons Laboratories Limited - Market Research Report
Company Overview
Name: Ferozsons Laboratories Limited
- Mission: To improve the quality of life by providing innovative healthcare solutions, ensuring patient access to treatment and cure.
- Founded: 1956 by Maulvi Ferozuddin Khan.
- Key People:
- Chairperson and Chief Executive (1992): Akhter Khalid Waheed
- CEO and Director: Osman Khalid Waheed
- Headquarters:
- Registered Office: 197-A, The Mall, Rawalpindi, Rawalpindi-42000, Pakistan
- Head Office: 5 KM Sundar Raiwind Road, Raiwind, Lahore, Pakistan
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: Leadership in the manufacture and distribution of pharmaceuticals, with a specialization in gastroenterology, hepatology, cardiology, and oncology.
Products
Pharmaceuticals and Medical Technologies
Pharma & OTC
- Acylex Tablets
- Description: No information is available.
- Key Features: No information is available.
- Apreon Capsules
- Description: No information is available.
- Key Features: No information is available.
- Atenorm
- Description: No information is available.
- Key Features: No information is available.
- Aurora Tablets
- Description: No information is available.
- Key Features: No information is available.
- Azobar Series (500mg, 250mg, 30ml Suspension)
- Description: No information is available.
- Key Features: No information is available.
- Bio-Freeze
- Description: No information is available.
- Key Features: No information is available.
- Xirconi Cream
- Description: No information is available.
- Key Features: No information is available.
- Medical Technologies Division
- Boston Scientific Corporation: Ferozsons distributes products for cardiology, G.I. endoscopy, oncology, and more.
- Ziehm Imaging GmbH: Partnership for C-ARM medical technology.
- MAVIG GmbH: Marketing of radiation protection equipment.
International Partnerships
- Gilead Sciences, Inc.: Partnering for HBV, HCV, and HIV products.
- Bagó Group: Joint venture for BF Biosciences Limited – a biotech pharmaceutical manufacturing company.
- BioGaia: Line of probiotics.
- PanTheryx: Nutritional supplements for improving intestinal health.
- Performance Health, Inc.: Biofreeze pain relief products.
Recent Developments
New Products Launched
- DiaResQ sachets: Launched in partnership with PanTheryx for diarrhea relief.
- Remidia (Remdesivir injections): Produced for COVID-19 treatment under license from Gilead Sciences, Inc.
New Partnerships and Initiatives
- Rizq Foundation Collaboration: Ferozsons Omega Initiative to combat hunger.
- Telehealth Platform Development: Partnership with HospitALL for virtual counseling amid COVID-19.
- Corporate Coalition for Viral Hepatitis Elimination: Partnered with 12 companies to support the eradication of hepatitis by 2030.
- Health Net Pakistan Collaboration: Tackling diabetes and hepatitis awareness via educational and training initiatives.
- Art Projects: Collaborations with various organizations to incorporate art in clinical settings to improve healthcare environments.
New Features Added
- Project ECHO by Health Net Pakistan: Aimed at increasing awareness for hepatitis.
- Educational Initiatives: Liver Summit and medical education for over 250 physicians on liver diseases.
- Drug Safety Campaign: Social media initiative to educate on the importance of drug safety and adverse event reporting.
Contact Information
Registered Office
- 197-A, The Mall, Rawalpindi, Rawalpindi-42000, Pakistan
- Email: info@ferozsons-labs.com
- Phone: +92-51-4252150-53/55, +92-51-4252152-57
Head Office
- 5 KM Sundar Raiwind Road, Raiwind, Lahore, Pakistan
- Email: info@ferozsons-labs.com, info@bfbio.com
- Phone: +92-42-36026700, +92-42-36026702
Pharma Factory
- P.O.Ferozsons, Amangarh - Nowshera (Khyber Pakhtunkhwa)
- Email: info@ferozsons-labs.com
- Phone: +92-923-614295, 610159, 611302
Note: No information is available for fields not explicitly mentioned in the data provided.
© Copyright Ferozsons Laboratories Limited 2004 - 2024 all rights reserved. Designed & Developed by A2Z Creatorz
